Granules India rises on USFDA EIR with VAI classification

3 Jun 2026via Business StandardSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Granules India rises on USFDA EIR with VAI classification. Its subsidiary received an Establishment Inspection Report (EIR) from the USFDA with Voluntary Action Indicated (VAI) status post-inspection. This clears a key regulatory hurdle for exports to the US market. 📊 STOCKS: GRANULES | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA

#USFDA#inspection#GranulesIndia

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →